Page last updated: 2024-08-23

substance p and Angor Pectoris

substance p has been researched along with Angor Pectoris in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, Z; Niu, YL; Yao, TP; Zhang, JW	1
Akai, K; Funakoshi, M; Isoyama, S; Komaru, T; Nishioka, O; Nozaki, E; Sekiguchi, N; Shiba, N; Shirato, K; Tamaki, K; Yasuda, S; Zuguchi, M	1
Crake, T; Davies, GJ; Katsimaglis, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P	1
Alhaddad, R; Bender, H; Kambam, JR; Merrill, W; Naukam, R; Parris, W; Sastry, BV; Stewart, J	1
Kambam, JR; Kruskal, JB; Naukam, RJ; Parris, WC	1

Trials

1 trial(s) available for substance p and Angor Pectoris

Article	Year
Coronary angioplasty ameliorates hypoperfusion-induced endothelial dysfunction in patients with stable angina pectoris. Journal of the American College of Cardiology, 1996, Volume: 27, Issue:1 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Follow-Up Studies; Humans; Injections, Intra-Arterial; Male; Middle Aged; Nitroglycerin; Observer Variation; Prospective Studies; Regression Analysis; Risk Factors; Stroke Volume; Substance P; Vasodilator Agents	1996

Article

Year

Coronary angioplasty ameliorates hypoperfusion-induced endothelial dysfunction in patients with stable angina pectoris.

Journal of the American College of Cardiology, 1996, Volume: 27, Issue:1

Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Follow-Up Studies; Humans; Injections, Intra-Arterial; Male; Middle Aged; Nitroglycerin; Observer Variation; Prospective Studies; Regression Analysis; Risk Factors; Stroke Volume; Substance P; Vasodilator Agents

1996

Other Studies

4 other study(ies) available for substance p and Angor Pectoris

Article	Year
Coronary artery occlusion alters expression of substance P and its mRNA in spinal dorsal horn in rats. Neuroscience, 2007, Mar-16, Volume: 145, Issue:2 Topics: Afferent Pathways; Angina Pectoris; Animals; Coronary Stenosis; Ganglia, Spinal; Gene Expression Regulation; Heart; Male; Myocardial Ischemia; Neurons, Afferent; Nociceptors; Posterior Horn Cells; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Tachykinins	2007
Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries. The American journal of cardiology, 1998, Nov-01, Volume: 82, Issue:9 Topics: Aged; Angina Pectoris; Arginine; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Substance P; Vasoconstriction	1998
Substance P, acetylcholinesterase, and beta-endorphin levels in the plasma and pericardial fluid of patients with and without angina pectoris. The Journal of laboratory and clinical medicine, 1990, Volume: 116, Issue:5 Topics: Acetylcholinesterase; Angina Pectoris; beta-Endorphin; Body Fluids; Humans; Pericardium; Proteins; Substance P	1990
The effects of neurokinin A, neurokinin B, and eledoisin on substance P analysis. Journal of clinical monitoring, 1991, Volume: 7, Issue:2 Topics: Angina Pectoris; Back Pain; Carcinoid Tumor; Eledoisin; Humans; Neurokinin A; Neurokinin B; Pericardial Effusion; Protein Binding; Saliva; Species Specificity; Substance P	1991